Navoban


Indications and Reactions:

Role Indications Reactions
Primary
Breast Cancer 100.0%
Vomiting 100.0%
Secondary
Breast Cancer 26.0%
Breast Cancer Metastatic 21.1%
Product Used For Unknown Indication 6.5%
Nausea 4.9%
Pain 4.9%
Prophylaxis 4.1%
Anxiety Disorder 3.3%
Chemotherapy 3.3%
Post Procedural Vomiting 3.3%
Vomiting 3.3%
Colon Cancer 2.4%
Hypertension 2.4%
Metastases To Pleura 2.4%
Psoas Abscess 2.4%
Acute Myeloid Leukaemia 1.6%
Depression 1.6%
Hypothyroidism 1.6%
Insomnia 1.6%
Metastases To Bone 1.6%
Neutropenia 1.6%
Tongue Neoplasm Malignant Stage Unspecified 22.2%
Pyrexia 7.4%
Sensory Loss 7.4%
Stevens-johnson Syndrome 7.4%
Vomiting 7.4%
Blood Creatine Increased 3.7%
Blood Urea Increased 3.7%
Clonic Convulsion 3.7%
Confusional State 3.7%
Death 3.7%
Hot Flush 3.7%
Metastases To Pleura 3.7%
Myocardial Infarction 3.7%
Ovarian Cancer Metastatic 3.7%
Sensory Disturbance 3.7%
Thrombocytopenia 3.7%
Toxicity To Various Agents 3.7%
Type I Hypersensitivity 3.7%
Concomitant
Drug Use For Unknown Indication 27.6%
Prophylaxis 17.7%
Product Used For Unknown Indication 11.2%
Breast Cancer 9.4%
Non-small Cell Lung Cancer 4.7%
Premedication 3.7%
Prophylaxis Of Nausea And Vomiting 3.4%
Anaplastic Astrocytoma 2.4%
Gastric Cancer 2.0%
Glioblastoma Multiforme 2.0%
Non-hodgkin's Lymphoma 2.0%
Antifungal Prophylaxis 1.9%
Hypertension 1.8%
Colon Cancer 1.7%
Antiemetic Supportive Care 1.7%
Acute Lymphocytic Leukaemia 1.5%
Cardiac Failure Chronic 1.4%
Pain Prophylaxis 1.4%
Chemotherapy 1.3%
Colorectal Cancer Metastatic 1.2%
White Blood Cell Count Decreased 18.5%
Vomiting 12.8%
Death 6.7%
Febrile Neutropenia 5.6%
Pneumonia 5.1%
Anaemia 4.6%
Pulmonary Embolism 4.1%
Radiation Oesophagitis 4.1%
Malignant Neoplasm Progression 3.6%
Nausea 3.6%
Pneumonitis 3.6%
Pyrexia 3.6%
Renal Failure Acute 3.6%
White Blood Cell Count Increased 3.6%
Diarrhoea 3.1%
Renal Failure 3.1%
Somnolence 3.1%
Fasciitis 2.6%
Rash 2.6%
Tachycardia 2.6%

Drug Data